Close Menu
Home » Dmitry Samarsky, Steven Tregay

Dmitry Samarsky, Steven Tregay

Jun 28, 2007
Premium
RXi, the RNAi subsidiary of CytRx, has named Dmitry Samarsky as its vice president of technology development.
 
Samarsky was most recently director of technology development at Dharmacon, a unit of Thermo Fisher Scientific. Prior to that, he was business development manager at Invitrogen.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Collins to Avoid 'Manels'

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Patient Dies Following Fecal Transplant

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

From Pigs to Monkeys

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

This Week in Science

In Science this week: almond reference genome, and more.

What's Popular?

In Gene Silencing/Gene Editing

  1. GlaxoSmithKline, UC's Doudna Establish $67M Genomics, CRISPR Research Lab

  2. CRISPR DNA Base Editors Cause Tens of Thousands of Off-Target RNA Mutations

  3. Ginkgo Bioworks Takes $80M Stake in Synlogic as Part of Platform Collaboration

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.